Key insights
- Raymond James raised its price target for American Healthcare REIT (AHR) to $72 from $62, maintaining a Strong Buy rating, citing platform strength and accelerating investments. The firm increased its estimates by 15%, reflecting confidence in AHR's senior housing operations and Trilogy's embedded platform. AHR recently reported strong Q3 earnings, beating expectations and raising its full-year outlook, while also launching a $1.75 billion at-the-market equity offering.
Investing.com - Raymond James raised its price target on American Healthcare REIT, Inc. shares (NYSE:AHR) to $72 from $62 while maintaining a Strong Buy rating. The stock currently trades at $58.96, near its 52-week high of $59.22, and has delivered a strong 27% return year-to-date.
The firm increased its estimates by approximately 15% and raised the price target by more than 10%. The upgrade reflects confidence in the company’s position within the senior housing sector.
Raymond James cited the continued success of Trilogy’s operating platform embedded within American Healthcare REIT. The firm noted the company’s ability to leverage the platform across a growing base of senior housing operating property assets.
The analyst pointed to accelerating investments and pipeline opportunities. These developments are expected to enhance long-term performance across the company’s integrated senior health campus and senior housing operating property segments.
The firm said the investments would provide modest near-term accretion. Raymond James continues to favor American Healthcare REIT as a core platform company within senior housing.According to InvestingPro analysis, the stock appears overvalued at current levels. Investors seeking deeper insights can access a comprehensive Pro Research Report, available for AHR and 1,400+ other US equities.
In other recent news, American Healthcare REIT reported its third-quarter earnings, showcasing strong performance with a 31.8% increase in normalized funds from operations, reaching $0.58 per diluted share. The company also reported revenue of $742.15 million for the quarter and subsequently raised its full-year financial outlook. These developments indicate robust operating momentum across its senior housing and skilled nursing platforms.
Additionally, American Healthcare REIT has launched an at-the-market equity offering program, allowing for the potential sale of up to $1.75 billion in common stock. This agreement involves several financial institutions, including BofA Securities and Morgan Stanley & Co., among others, enabling the company to sell shares based on market conditions. The sales may be executed through various methods such as ordinary brokers’ transactions or block trades. These recent developments reflect American Healthcare REIT’s strategic efforts to optimize its financial position and capitalize on market opportunities.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
That's one option. But ProPicks AI re-evaluates AHR alongside thousands of other companies every month, using 100+ financial metrics, and it may have found you a better stock. ProPicks AI looks past headlines and Reddit to fundamentals, momentum and valuation. You get the rationale behind every pick, so you can check the logic before you act on it. Over three years, our strategies have returned 2.3X the S&P 500's returns. Find out whether AHR made this month's lists, and which stocks in the same space did. Now 55% off for Black Friday early birds.